Ishikawa, Satoshi
Nishida, Naohiro
Fujino, Shiki
Ogino, Takayuki
Takahashi, Hidekazu
Miyoshi, Norikatsu
Uemura, Mamoru
Satoh, Taroh
Yamamoto, Hirofumi
Mizushima, Tsunekazu
Doki, Yuichiro
Eguchi, Hidetoshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP19K16772)
Article History
Received: 11 October 2020
Accepted: 21 May 2021
First Online: 3 June 2021
Competing interests
: N. Nishida: Yakult Honsha Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd. T. Satoh: Yakult Honsha Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd. All other authors have declared no conflicts of interest regarding this study.